Please assess the completion status of the following clinical trial:

Trial Title: Effects of Platelet Rich Plasma on Endometrium

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women in whom cycle was cancelled due to an endometrial thickness \<7 mm when progesterone start was planned in patients undergoing frozen embryo transfer with hormone replacement therapy~* Women with a history of Asherman syndrome, but no obvious intrauterine adhesion in the last hysteroscopic procedure;~* Women who have at least 2 frozen good-quality embryos.~Exclusion Criteria:~* Women with any other known cause of implantation failure, such as poor embryo quality, or congenital uterine anomalies, endometrial polyp or fibroid,~* Previous diagnosis of any malignancy,~* Anticoagulant use for which plasma infusion is contraindicated,

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Endometrial PRP (Type: EXPERIMENTAL): Patients in whom endometrial PRP was performed

Based on this trial design, predict the completion outcome and termination type (if applicable).